Ardent Health, Inc.
ARDT
$11.25
$0.262.37%
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 6.41B | 6.43B | 6.32B | 6.33B | 6.20B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 6.41B | 6.43B | 6.32B | 6.33B | 6.20B |
| Cost of Revenue | 2.67B | 2.66B | 2.66B | 2.66B | 2.62B |
| Gross Profit | 3.74B | 3.77B | 3.67B | 3.67B | 3.58B |
| SG&A Expenses | 2.62B | 2.58B | 2.54B | 2.50B | 2.44B |
| Depreciation & Amortization | 164.52M | 162.49M | 155.70M | 152.52M | 150.14M |
| Other Operating Expenses | 692.83M | 681.69M | 647.31M | 634.55M | 553.53M |
| Total Operating Expenses | 6.15B | 6.09B | 6.00B | 5.95B | 5.77B |
| Operating Income | 257.90M | 339.41M | 325.58M | 378.40M | 432.32M |
| Income Before Tax | 207.96M | 286.75M | 286.36M | 361.23M | 420.50M |
| Income Tax Expenses | 39.32M | 57.09M | 56.22M | 64.47M | 78.94M |
| Earnings from Continuing Operations | 168.65 | 229.66 | 230.14 | 296.76 | 341.56 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -90.42M | -95.38M | -94.32M | -91.71M | -86.70M |
| Net Income | 78.23M | 134.28M | 135.81M | 205.06M | 254.86M |
| EBIT | 257.90M | 339.41M | 325.58M | 378.40M | 432.32M |
| EBITDA | 422.42M | 501.89M | 481.29M | 530.92M | 582.46M |
| EPS Basic | 0.55 | 0.95 | 0.97 | 1.46 | 1.82 |
| Normalized Basic EPS | 0.31 | 0.63 | 0.54 | 0.78 | 1.06 |
| EPS Diluted | 0.55 | 0.95 | 0.96 | 1.45 | 1.81 |
| Normalized Diluted EPS | 0.31 | 0.62 | 0.53 | 0.78 | 1.05 |
| Average Basic Shares Outstanding | 565.54M | 564.23M | 563.02M | 561.71M | 557.59M |
| Average Diluted Shares Outstanding | 568.15M | 566.62M | 565.55M | 564.28M | 560.59M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |